Endotoxin inhibitor is a synthetic ligand featuring hydrophobic and charged functionalities that modulate biomolecular recognition. Researchers employ it to examine noncovalent interaction networks, conformational stability, and solvent-driven orientation. Its structure supports detailed mechanistic modeling. The compound's versatility aids biochemical investigation.
CAT No: R2304
CAS No:147396-10-9
Synonyms/Alias:Endotoxin inhibitor;147396-10-9;(4R,7S,10S,13S,16S,19S,22R)-7,10,19-tris(4-aminobutyl)-22-[[(2S)-6-amino-2-[[(2S,3R)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-16-benzyl-13-(2-methylpropyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricosane-4-carboxylic acid;MFCD00214319;HY-P3912;DA-52899;FE108431;PD159225;CS-0627813;H-Lys-Thr-Lys-Cys-Lys-Phe-Leu-Lys-Lys-Cys-OH; H-KTKCKFLKKC-OH;
2. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
5. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.